Alzheimer's disease

Medicare says it will limit coverage of a $28,000-a-year Alzheimer’s drug whose benefits have been widely questioned

U.S. health secretary Xavier Becerra is ordering Medicare to reassess a big premium increase facing millions of seniors this year

Biogen’s Alzheimer’s drug Aduhelm was heralded as a historic triumph against the memory-robbing disease. Now, the company is trying to keep it afloat.

A Maine state trooper has come to the aid of an elderly man with Alzheimer’s disease who had wandered away from his home during a storm and ended up in a ditch. Troopers got their missing person report from a home in Vassalboro at about 5 a.m. Wednesday. They also received information from a town plow truck driver that...

Waiting to talk to an aging parent about their financial future until they experience cognitive decline is a mistake, say financial advisors.

Billions of dollars are stolen from seniors each year. Financial fraud and exploitation is the most prevalent form of elder abuse.

A clinical trial for a nasal vaccine for Alzheimer’s will soon be underway at Brigham and Women’s Hospital.

Brigham and Women’s Hospital is launching the first human clinical trial for a nasal vaccine for Alzheimer’s disease.

A Connecticut woman was arrested Wednesday, accused of stealing $600,000 from her husband by convincing him he had Alzheimer’s disease in order to hide it from him, police said.

Persistent concerns about the first new Alzheimer’s treatment in more than 20 years are curbing access more than four months after regulators approved it.

A daily diet of colorful fruits and vegetables can help make your brain strong, sharper and smarter, studies show. Here’s what a Harvard nutritional psychiatrist eats to strengthen her memory, focus and overall health.

Insurance companies are weighing whether to cover Biogen’s controversial new drug for Alzheimer’s disease, which has an annual cost of $56,000.

A month after approving a controversial new Alzheimer’s drug, the FDA has signed off on new prescribing instructions to limit its use to only patients with early or mild cases of the disease. The acting head of the FDA, Dr. Janet Woodcock, also announced that she was ordering an investigation into whether the agency acted improperly in approving the...

The acting head of the Food and Drug Administration is calling for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug

Doctors are trying to figure out who should get a new treatment for Alzheimer’s disease

Biogen Alzheimer’s drug Aduhelm is the first new treatment for dementia approved by the FDA in decades, and it’s started a war over the brain drug pipeline.

Federal regulators have approved the first new drug for Alzheimer’s disease in nearly 20 years, leaving patients waiting to see how insurers will handle the pricey new treatment

The FDA has approved a controversial drug for Alzheimer’s disease developed by Cambridge-based pharmaceutical company Biogen.

Government health officials have approved the first drug that they say may help slow Alzheimer’s disease

Peter Marshall and his wife, Lisa, have been married for 12 years. But with Peter battling early onset Alzheimer’s that he was diagnosed with a few years ago, he doesn’t remember that wedding happening — he just knows that he loves Lisa.